Two-year safety and efficacy outcomes for the treatment of overactive bladder using a long-lived rechargeable sacral neuromodulation system.

Bertil F M BlokPhilip Van KerrebroeckStephan de WachterAlain RuffionFrank Van der AaMarie Aimée Perrouin-VerbeSohier Elneil

Published in: Neurourology and urodynamics (2020)

The Axonics System® provides sustained clinically meaningful improvements in OAB subjects at 2 years. There were no serious device-related AEs. Subjects reported continued satisfaction with their therapy.

Keyphrases

stem cells
type diabetes
mesenchymal stem cells
combination therapy
metabolic syndrome
adipose tissue
skeletal muscle
weight loss
cell therapy